# Buprenorphine

NDC: 3215-1525
Generic name: Buprenorphine
Labeler / Manufacturer: Aveva Drug Delivery Systems Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PATCH, EXTENDED RELEASE
Routes: TRANSDERMAL
Marketing started: 20231101

FDA application: ANDA210272

## Active ingredients

- BUPRENORPHINE: 20 ug/h

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"3215-1525"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=3215-1525
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1aae9b13-7431-42ef-8558-14a2325820e6